Françoise Bridey Selected Research

von Willebrand Factor

1/2023	Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin®) in paediatric patients under 6 years of age with severe von Willebrand disease.
8/2022	Continuous Infusion of Factor VIII and von Willebrand Factor in Surgery: Trials with pdFVIII LFB or pdVWF LFB in Patients with Bleeding Disorders.
1/2020	Management of von Willebrand disease with a factor VIII-poor von Willebrand factor concentrate: Results from a prospective observational post-marketing study.
1/2012	Biological determinants of bleeding in patients with heterozygous factor XI deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Françoise Bridey Research Topics

Disease

3	von Willebrand Diseases (von Willebrand's Disease) 01/2023 - 01/2020
3	Hemorrhage 08/2022 - 01/2012
3	Afibrinogenemia (Fibrinogen Deficiency) 06/2020 - 01/2019
1	Hemophilia A (Haemophilia) 08/2022
1	Body Weight (Weight, Body) 01/2020

Drug/Important Bio-Agent (IBA)

4	von Willebrand FactorIBA 01/2023 - 01/2012
3	Factor VIII (Coagulation Factor VIII)IBA 01/2023 - 01/2020
3	Fibrinogen (Factor I)FDA Link 06/2020 - 01/2019
1	A-factor (Streptomyces)IBA 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Factor XIII (Coagulation Factor XIII)IBA 01/2019
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2012
1	AntigensIBA 01/2012
1	ThrombomodulinIBA 01/2012
1	Thrombin FDA Link 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012

Therapy/Procedure

2	Therapeutics 08/2022 - 01/2019
1	Injections 08/2022